Jorma Lehtonen

Title: Jorma Lehtonen: Innovator in Pyridazinone Derivatives

Introduction

Jorma Lehtonen is a notable inventor based in Kuohu, Finland. He has made significant contributions to the field of chemistry, particularly in the development of methods for obtaining pure enantiomers. His work is recognized for its potential applications in pharmaceuticals and other industries.

Latest Patents

Lehtonen holds a patent for a method for obtaining pure enantiomers of a pyridazinone derivative. The patent describes a process for preparing optically active enantiomers of a specific compound, particularly the (-) enantiomer. Additionally, the invention introduces a novel crystalline polymorphic form of the (-) enantiomer, showcasing his innovative approach to chemical synthesis.

Career Highlights

Jorma Lehtonen is associated with Orion Corporation, a prominent company in the pharmaceutical industry. His work at Orion has allowed him to focus on research and development, contributing to advancements in drug formulation and synthesis.

Collaborations

Lehtonen has collaborated with several colleagues, including Veli Pekka Tanninen and Riikka Hyppöla. These partnerships have fostered a collaborative environment that enhances the innovation process within the company.

Conclusion

Jorma Lehtonen's contributions to the field of chemistry, particularly through his patent on pyridazinone derivatives, highlight his role as an innovator. His work continues to influence the pharmaceutical industry and showcases the importance of research and collaboration in driving advancements.